The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Breast cancer and NSAID use: a meta-analysis
Open accessAbstract
Recent epidemiological studies suggest that non-steroidal anti-inflammatory drugs (NSAIDs) reduce the risk of several cancers including breast cancer. This meta-analysis examined the studies on NSAID use and breast cancer. The estimators of relative risk and associated variances, which have been adjusted for the greatest number of confounders, were abstracted and included in the meta-analysis. Combined estimators of relative risk (RR) were calculated using either fixed or random effect models. Meta-analyses were performed on 6 cohort studies (number of cases ranged from 14 to 2414) and 8 case-control studies (number of cases ranged from 252 to 5882). The combined estimate of relative risk was 0.82 (95% confidence interval [CI] = 0.75-0.89). The combined estimate for cohort studies was 0.78 (95% CI = 0.62-0.99) and was 0.87 (95% CI = 0.84-0.91) for case-control studies. The findings of this meta-analysis suggest that NSAID use may be associated with a small decrease in the risk of breast cancer. However, the available data are insufficient to estimate the dose-response effect for duration and frequency of use of any particular types of NSAID.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
The combination of estimates from different experiments
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001666 · Cited by 5,380
Reproductive Factors and Breast Cancer
Kelsey, J. L., Gammon, M. D., & John, E. M. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036115 · Cited by 1,446
Aspirin use and risk of fatal cancer.
Thun, M. J., Namboodiri, M. M., Calle, E. E., Flanders, W. D., & Heath, C. W. (1993) · PubMed · Cited by 870
Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study
Schreinemachers, D. M., & Everson, R. B. (1994) · Epidemiology · doi:10.1097/00001648-199403000-00003 · Cited by 736
Proportion of Breast Cancer Cases in the United States Explained by Well-Established Risk Factors
Madigan, M. P., Ziegler, R. G., Benichou, J., Byrne, C., & Hoover, R. N. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.22.1681 · Cited by 655
Expression of Cyclooxygenase-1 and Cyclooxygenase-2 in Human Breast Cancer
Hwang, D., Byrne, J., Scollard, D., & Levine, E. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.6.455 · Cited by 651
Incidence of Cancer Among Patients With Rheumatoid Arthritis
Gridley, G., McLaughlin, J. K., Ekbom, A., Klareskog, L., Adami, H.-O., Hacker, D. G., Hoover, R., & Fraumeni, J. F. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.4.307 · Cited by 581
Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.
Harris, R. E., Alshafie, G. A., Abou‐Issa, H., & Seibert, K. (2000) · PubMed · Cited by 540
A Hypothesis: Nonsteroidal Anti-Inflammatory Drugs Reduce the Incidence of Large-Bowel Cancer
Rosenberg, L., Palmer, J. R., Zauber, A. G., Warshauer, M. E., Stolley, P. D., & Shapiro, S. (1991) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/83.5.355 · Cited by 501
Langman, M. J. S. (2000) · BMJ · doi:10.1136/bmj.320.7250.1642 · Cited by 419
Aspirin use and chronic diseases: a cohort study of the elderly.
Paganini-Hill, A., Chao, A., Ross, R. K., & Henderson, B. E. (1989) · BMJ · doi:10.1136/bmj.299.6710.1247 · Cited by 396
Rheumatoid arthritis and cancer risk
Mellemkjær, L., Linet, M. S., Gridley, G., Frisch, M., Møller, H., & Olsen, J. H. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00210-9 · Cited by 383
Nonsteroidal Antiinflammatory Drugs and Breast Cancer
Harris, R. E., Namboodiri, K. K., & Farrar, W. B. (1996) · Epidemiology · doi:10.1097/00001648-199603000-00017 · Cited by 345
Sharpe, C. R., Collet, J.-P., McNutt, M., Belzile, E., Boivin, J.-F., & Hanley, J. A. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1119 · Cited by 187
Prospective Study of Regular Aspirin Use and the Risk of Breast Cancer
Egan, K. M., Stampfer, M. J., Giovannucci, E., Rosner, B. A., & Colditz, G. A. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.14.988 · Cited by 183
Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer.
Harris, R. E., Kasbari, S., & Farrar, W. B. (1999) · Oncology Reports · doi:10.3892/or.6.1.71 · Cited by 175
Mechanism of inhibition of tumour growth by aspirin and indomethacin
Lynch, N. R., Castes, M., Astoin, M., & Salomon, J. C. (1978) · British Journal of Cancer · doi:10.1038/bjc.1978.237 · Cited by 174
Initial Screening for Carcinogenicity of Commonly Used Drugs23
FRIEDMAN, G. D., & Ury, H. K. (1980) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/65.4.723 · Cited by 148
Association between coronary heart disease and cancers of the breast, prostate, and colon.
Neugut, A. I., Rosenberg, D. J., Ahsan, H., Jacobson, J. S., Wahid, N., Hagan, M., Rahman, M. I., Khan, Z. R., Chen, L., Pablos-Méndez, A., et al. (1998) · PubMed · Cited by 142
Nonsteroidal Anti-inflammatory Drugs and Cancer
Rosenberg, L. A. (1995) · Preventive Medicine · doi:10.1006/pmed.1995.1018 · Cited by 71
Lala, P. K., Al-Mutter, N., & Orucevic, A. (1997) · International Journal of Cancer · Cited by 65
Wun, L., Feuer, E. J., & Miller, B. A. (1995) · Cancer Causes & Control · doi:10.1007/bf00052774 · Cited by 45
Dinse, G. E., Umbach, D. M., Sasco, A. J., Hoel, D. G., & Davis, D. L. (1999) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.20.1.173 · Cited by 34
Breast cancer, its recurrence, and patient survival in relation to tumor prostaglandins.
Bennett, A. B., Berstock, D. A., Carroll, M. A., Stamford, I. F., & Aj, W. (1983) · PubMed · Cited by 26
Cited by
Thun, M. J., Henley, S. J., & Patrono, C. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.4.252 · Cited by 1,433
Cook, N. R., Lee, I.-M., Gaziano, J. M., Gordon, D., Ridker, P. M., Manson, J. E., Hennekens, C. H., & Buring, J. E. (2005) · JAMA · doi:10.1001/jama.294.1.47 · Cited by 796
Aspirin Intake and Survival After Breast Cancer
Holmes, M. D., Chen, W. Y., Li, L., Hertzmark, E., Spiegelman, D., & Hankinson, S. E. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.7918 · Cited by 365
Natural withanolides: an overview
Chen, L.-X., He, H., & Qiu, F. (2011) · Natural Product Reports · doi:10.1039/c0np00045k · Cited by 358
Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer
Howe, L. R. (2007) · Breast Cancer Research · doi:10.1186/bcr1678 · Cited by 293
Metadata
- Authors
- Khuder, S. A., & Mutgi, A. B.
- Venue
- British Journal of Cancer
- Published
- 2001
- Volume
- 84
- Issue
- 9
- Pages
- 1188-1192
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2053071688
- Cited by
- 273
- References
- 26
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.